Researchers develop a compact promoter that could unlock gene therapies for drug-resistant epilepsy (IMAGE)
Caption
Drug-resistant epilepsy remains a challenge even now, severely impacting the quality of life for patients. Now, however, researchers from Gunma University have found a way to address this challenge by demonstrating how viral vector technology could become a valuable tool for challenging neurological and neuropsychiatric disorders.
Credit
Professor Hirokazu Hirai from Gunma University, Japan
Usage Restrictions
Cannot be reused without permission.
License
Original content